Epstein Secrets

g it a `giant logistical project;" and he "said the GSA's stonewalling is making that difficult." The AP (11/15, Alonso-Zaldivar, Weissert) reports Klain "said Biden's experts also need a detailed understanding of distribution plans being finalized by the Department of Health and Human Services and t

dlined "Biden Turns Up Pressure for Administration Recognition" provides similar coverage, as does the Washington Times (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key offici

imeline depends on the Food and Drug Administration authorizing the emergency use of one or more vaccines — which could happen in a matter of weeks, Slaoui noted." Vaccine Hesitancy, Supply Chain Among Hurdles To Vaccine Distribution. The Washington Post (11/13, Fadulu, 14.2M) reports, "Regional coordi

g it a `giant logistical project;" and he "said the GSA's stonewalling is making that difficult." The AP (11/15, Alonso-Zaldivar, Weissert) reports Klain "said Biden's experts also need a detailed understanding of distribution plans being finalized by the Department of Health and Human Services and t

dlined "Biden Turns Up Pressure for Administration Recognition" provides similar coverage, as does the Washington Times (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key offici

imeline depends on the Food and Drug Administration authorizing the emergency use of one or more vaccines — which could happen in a matter of weeks, Slaoui noted." Vaccine Hesitancy, Supply Chain Among Hurdles To Vaccine Distribution. The Washington Post (11/13, Fadulu, 14.2M) reports, "Regional coordi

g it a `giant logistical project;" and he "said the GSA's stonewalling is making that difficult." The AP (11/15, Alonso-Zaldivar, Weissert) reports Klain "said Biden's experts also need a detailed understanding of distribution plans being finalized by the Department of Health and Human Services and t

dlined "Biden Turns Up Pressure for Administration Recognition" provides similar coverage, as does the Washington Times (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key offici

imeline depends on the Food and Drug Administration authorizing the emergency use of one or more vaccines — which could happen in a matter of weeks, Slaoui noted." Vaccine Hesitancy, Supply Chain Among Hurdles To Vaccine Distribution. The Washington Post (11/13, Fadulu, 14.2M) reports, "Regional coordi